Procter & Gamble Health
BSE: 500126 | NSE: PGHL | ISIN: INE199A01012 | SECTOR: Biotechnology & DrugsOpen
4,719.75High
4,732.85Low
4,677.35Prev Close
4,681.30P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
78.12BVolume
0.44KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
500126NSE
PGHLISIN
INE199A01012
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
Company Officers
Lokesh Chandak
Chief Financial Officer, Additional Executive DirectorZeal Rupani
Compliance Officer, Company SecretaryMilind Thatte
Managing Director, Executive Director